Latest News & Features
Americas
LSIPR's senior reporter Marisa Woutersen speaks with Mythili Markowski of Regeneron on why new USPTO guidance is putting post-grant proceedings under the spotlight and how in-house teams are responding. 8 May 2026
Europe
Experts from Johnson & Johnson and Novartis took the stage at INTA to share the pitfalls lurking inside mergers, acquisitions and spin-offs and what in-house counsel can do about them. 7 May 2026
Americas
A California judge has denied Corcept’s bid to dismiss the lawsuit over its drug for a rare hormonal disorder, allowing the litigation to proceed on all core counts. 7 May 2026
Europe
Panellists at INTA share how workplaces can bridge generational divides and why those differences may be a team’s biggest strengths. 6 May 2026
Careers
The new partner, a former entrepreneur and self-proclaimed ‘hardcore programmer’, brings patent litigation savvy to the firm. 6 May 2026
Americas
J&J’s Abiomed can proceed with its non-infringement defence despite potential future appellate reversal, in a week when both parties in the case were dealt wins and losses in their clash over Impella devices. 5 May 2026
Europe
John Ward, vice president and associate general counsel of trademarks at Moderna, chats with Tom Phillips at INTA 2026. 5 May 2026
Americas
LSIPR's senior reporter Marisa Woutersen speaks with Ben Doranz of Integral Molecular, fresh from the stage at LSPN Boston after speaking at a panel session on challenges in antibody patent protection. 4 May 2026
Americas
The Office of the US Trade Representative has placed the EU on its Watch List, outlining concerns about pharma legislation, GIs and digital copyright. 1 May 2026
Careers
The IP expert will use his new role to support clients in cross-border challenges driven by innovation, digitalisation, market pressure and regulatory change. 1 May 2026